4//SEC Filing
Lin Elizabeth Yeu 4
Accession 0001819790-24-000121
CIK 0001819790other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:40 PM ET
Size
7.7 KB
Accession
0001819790-24-000121
Insider Transaction Report
Form 4
Lin Elizabeth Yeu
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-11-04+41,074→ 41,074 totalExercise: $46.21Exp: 2034-11-03→ Common Stock (41,074 underlying) - Award
Restricted Stock Units
2024-11-04+27,278→ 27,278 total→ Common Stock (27,278 underlying)
Footnotes (3)
- [F1]Option granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001842190
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:40 PM ET
- Size
- 7.7 KB